MAPK3 and head and neck squamous cell carcinoma: GSPs have recently shown to concentration-dependent inhibit human cutaneous HNSCC cell invasion, which was associated with a reduction in the levels of epidermal growth factor receptor (EGFR) and the inhibition of the phosphorylation of ERK1/2, a member of mitogen-activated protein kinase family [57].